NB19-28 Disability Insurance and Treatment for Pain
Recent research finds that one-quarter of SSDI beneficiaries are chronic users of opioid prescription medicines, and roughly one-half of beneficiaries have had at least one opioid prescription. Is disability program participation a consequence of pain treatment with prescription opioids, or a route to obtaining affordable prescription opioids? This project will explore the relationship between the treatment of pain with prescription opioids and disability program participation, using newly developed Social Security Administrative data and commercial medical claims.
Supported by the Social Security Administration grant #DRC12000002
More from NBER
In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals — the NBER Reporter, the NBER Digest, the Bulletin on Retirement and Disability, the Bulletin on Health, and the Bulletin on Entrepreneurship — as well as online conference reports, video lectures, and interviews.